Recent Advances in the Treatment and Management of Endometrial Cancer

Activity Overview

Provided by

This activity is supported by an educational grant from Merck Sharp & Dohme.

Live Date: March 13, 2024
Expiration Date: March 13, 2025

Activity Description

This live activity is designed for oncologists, obstetrics & gynecologists, primary care physicians, nurses and pharmacists engaged in the care of patients with endometrial cancer. This activity will represent a thorough team approach to patient care.

Further, this activity will address the following needs:

• Clinicians require a review of risk factors and symptoms of endometrial cancer, as well as appropriate management of patients.
• Clinicians need further education regarding new and emerging medications for their patients, as well as important adverse effects related to these agents and their management.

Faculty Educators

Joan R. Tymon-Rosario, MD (activity chair)
Assistant Professor
Division of Gynecologic Oncology
Department of Obstetrics and Gynecology
Zucker School of Medicine
Northwell Health Cancer Institute

Eva Y. Pan, PharmD, BCOP (activity faculty)
Clinical Oncology Pharmacy Specialist
Yale-New Haven Hospital
New Haven, Connecticut

Arlene Donnatin, NP, RN (activity faculty)
Northwell Health Physician Partners
Gynecologic Oncology
New Hyde Park

Learning Objectives

After participating in the activity, learners should be better able to:

• Identify key risk factors for the development of endometrial cancer and appropriate management
• Describe the appropriate treatment for endometrial cancer based on the extent of disease
• Review the mechanism of action of novel agents and their place in therapy
• Describe adverse events related to new therapies for treatment of endometrial cancer
• Collaborate with an interprofessional team to create an evidence- based treatment plan based on a patient case

Accreditation and Credit Designation

In support of improving patient care, American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians
The Academy is a Provider approved by the California Board of Registered Nursing.
American Academy of CME, Inc., designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC
 Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn 1.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Pharmacists
This activity provides 1.5 ACPE contact hours (0.15 CEUs) of continuing education credit. Universal Activity Number JA4008191-0000-24-008-H01-P. Application

Nurse Practitioners and Nurses
American Academy of CME, Inc., designates this enduring educational activity for 1.5 ANCC contact hours (0.75 pharmacotherapeutic contact hours).

Other members of the care team will receive a certificate of participation.

Disclosures

According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers, and other individuals who are in a position to control content are required to disclose any relationships with any ineligible company(ies). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. Clinical content has been reviewed for fair balance and scientific objectivity, and all the relevant financial relationships listed for these individuals have been mitigated.

Disclosure of relevant financial relationships are as follows:

Faculty Educators and Planners
The faculty nor any of the planners have relevant financial relationships with ineligible companies to disclose.

Off-label-disclosure: This activity mentions drugs that are not currently indicated for the treatment of endometrial cancer.

The opinions expressed in this accredited continuing education activity are those of the faculty, and do not represent those of the Academy. This educational activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically and draw conclusions only after careful consideration of all available scientific information.

Independent Clinical Reviewer
Lisa Holle, PharmD, BCOP, FHOPA, FISOPP has no relevant financial relationships with ineligible companies to disclose.

Method of Participation

There are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CME/CNE/CPE/CE credit and for physicians to be eligible to earn ABIM MOC points for your participation, please complete the post-test (achieving a passing grade of 70% or greater), and program evaluation. Your certificate can be printed immediately.

For pharmacists, a statement of credit will be issued through CPE Monitor in 6-8 weeks. Only learners who provided valid NABP e-Profile ID numbers and month and day of birth (MMDD) will be submitted to CPE Monitor for official record of credit.

CLAIMING MOC POINTS: If you intend to claim MOC points for your participation, you will need to provide your unique ABIM ID when completing the activity evaluation. Physicians who do not know their ABIM ID can log in to the ABIM website at https://www.abim.org — your ABIM ID will appear next to your name.

By claiming MOC points, you are agreeing to have your participation completion information shared with the ACCME and the ABIM. Your points will be automatically submitted to the ABIM on your behalf; please allow 6-8 weeks for your points to display on the ABIM website.

Hardware/Software Requirements

Please ensure the computer you plan to use meets the following minimum requirements:

• Operating System: Windows 98 or higher & Macintosh 2.2 or higher
• Internet Browser (Mac &/ Windows): Internet Explorer 6.0 or higher, Google Chrome, Safari 5.0.6 or higher, Firefox 3.0.3 or higher & Opera 5 or higher
• Broadband Internet connection: Cable, High-speed DSL & any other medium that is internet accessible
• Monitor Screen Resolution: 320 x 480 or higher
• Media Viewing Requirements: Adobe Reader, Microsoft Powerpoint, Flash Player & HTML5

Privacy

For more information about the American Academy of CME privacy policy, please access http://www.academycme.org/privacy.htm

Contact

For any questions, please contact: CEServices@academycme.org

Copyright

© 2024. This accredited continuing education activity is held as copyrighted © by American Academy of CME. Through this notice, the Academy grant permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).